TokenPost·
FDA Approves NRx Pharmaceuticals’ Generic Ketamine Injection
NRx shares rose more than 15% in premarket trading Friday, Oct. 30. The approval may help ease U.S. supply constraints for ketamine used in pain treatment and anesthesia.
More news
- TokenPostHashKey RWA Launches First hToken Security With USDT Subscriptions
- TokenPost18,270 Bitcoin Tied to Binance Incident Splits Across 19 Wallets
- Bitcoin.com NewsCZ Tells Elon Musk to Stop Trolling Over $6.3B Binance Hack, Cites SpaceX Stake
- The DefiantUniswap, a16z and DEF Seek DeFi Exemptions From Illinois Crypto Tax Rules
- TokenPostDragonfly Partner Says Binance Hack Drew a Muted Market Response
- TokenPostExxon CEO Points to Diesel as a Key Refined-Fuel Pressure Point